{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:01:55Z","timestamp":1791338515252,"version":"4.3.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":3932,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1111\/j.1538-7836.2012.04623.x","type":"journal-article","created":{"date-parts":[[2012,1,11]],"date-time":"2012-01-11T12:47:16Z","timestamp":1326286036000},"page":"390-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Monitoring of plasma levels of activated protein C using a clinically applicable oligonucleotide\u2010based enzyme capture assay"],"prefix":"10.1016","volume":"10","author":[{"given":"J.","family":"M\u00dcLLER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"FRIEDRICH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"BECHER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"BRAUNSTEIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"KUPPER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"BERDEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"GRAVIUS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"ROHRBACH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"OLDENBURG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"MAYER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"P\u00d6TZSCH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0010","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nm0505-475","article-title":"Do\u2010all receptor takes on coagulation, inflammation","volume":"11","author":"Esmon","year":"2005","journal-title":"Nat Med"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0015","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1378\/chest.124.3_suppl.26S","article-title":"The Protein C pathway","volume":"124","author":"Esmon","year":"2003","journal-title":"Chest"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0020","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.1071699","article-title":"Activation of endothelial cell protease activated receptor 1 by the protein C pathway","volume":"296","author":"Riewald","year":"2002","journal-title":"Science"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1538-7836.2009.03660.x","article-title":"The discovery of the endothelial cell protein C receptor","volume":"8","author":"Esmon","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0030","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.2174\/092986710791233706","article-title":"Regulation of the protein C anticoagulant and anti\u2010inflammatory pathways","volume":"17","author":"Rezaie","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0035","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1172\/JCI44266","article-title":"New players in the sepsis\u2010protective activated protein C pathway","volume":"120","author":"Ruf","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0040","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood.V79.9.2340.2340","article-title":"Direct detection of activated protein C in blood from human subjects","volume":"79","author":"Gruber","year":"1992","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0045","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-0038-1651630","article-title":"A sensitive and facile assay for the measurement of activated protein C activity levels in vivo","volume":"69","author":"Orthner","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0050","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1538-7836.2003.00153.x","article-title":"A monoclonal antibody against activated protein C allows rapid detection of activated protein C in plasma and reveals a calcium ion dependent epitope involved in factor Va inactivation","volume":"1","author":"Liaw","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0055","unstructured":"Esmon CT, Ferrell GL, Liaw PCY. Assay for rapid detection of human activiated protein C and highly specific monoclonal antibody therefor. U.S. patent 6989241. http:\/\/www.patentgenius.com\/patent\/6989241.html. Accessed August 8, 2011."},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0060","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1055\/s-0037-1616093","article-title":"A sensitive immunochemical assay for measuring the concentration of the activated protein C\u2010protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed\/cleaved form of the inhibitor","volume":"86","author":"Strandberg","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0065","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1055\/s-0037-1613485","article-title":"Stabilyte tubes contain strongly acidic citrate prevent in vitro complex formation between activated protein C and protein C inhibitor","volume":"89","author":"Strandberg","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0070","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2516.2008.01957.x","article-title":"The plasma concentration of activated protein C appears normal in patients with haemophilia","volume":"15","author":"Schulman","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0075","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0049-3848(90)90418-C","article-title":"Determination of plasma protein C inhibitor and of two activated protein C\u2010inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease","volume":"59","author":"Espa\u00f1a","year":"1990","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0049-3848(95)00093-7","article-title":"Activation of the protein C pathway in acute sepsis","volume":"79","author":"Alcaraz","year":"1995","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0085","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1055\/s-0037-1616737","article-title":"Low level of circulating activated protein C is a risk factor for venous thromboembolism","volume":"86","author":"Espa\u00f1a","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0090","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.chembiol.2009.03.007","article-title":"An exosite\u2010specific ssDNA aptamer inhibits the anticoagulant functions of activated protein C and enhances inhibition by protein C inhibitor","volume":"16","author":"M\u00fcller","year":"2009","journal-title":"Chem Biol"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0095","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","article-title":"Calibrated automated thrombin generation measurement in clotting plasma","volume":"33","author":"Hemker","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0100","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1182\/blood.V88.6.2101.bloodjournal8862101","article-title":"Compound heterozygous protein C deficiency resulting in the presence of only the beta\u2010form of protein C in plasma","volume":"88","author":"Simioni","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0105","doi-asserted-by":"crossref","first-page":"9778","DOI":"10.1016\/S0021-9258(18)92888-7","article-title":"Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin","volume":"266","author":"Grinnell","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0110","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1002\/pmic.200800775","article-title":"N\u2010glycosylation microheterogeneity and site occupancy of an Asn\u2010X\u2010Cys sequon in plasma\u2010derived and recombinant protein C","volume":"9","author":"Gil","year":"2009","journal-title":"Proteomics"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0115","first-page":"1570","article-title":"Inhibition of coagulation by macromolecular complexes","volume":"90","author":"Gomez","year":"2005","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0120","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0049-3848(89)90292-2","article-title":"Aprotinin (trasylol) is a competitive inhibitor of activated protein C","volume":"56","author":"Espa\u00f1a","year":"1989","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2012.04623.x_bb0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0049-3848(90)90268-H","article-title":"Inhibition of activated protein C by aprotinin and the use of the insolubilized inhibitor for its purification","volume":"59","author":"Taby","year":"1990","journal-title":"Thromb Res"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2012.04623.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622062079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622062079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2012.04623.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:59:11Z","timestamp":1761533951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622062079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1538783622062079"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04623.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitoring of plasma levels of activated protein C using a clinically applicable oligonucleotide\u2010based enzyme capture assay","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04623.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}